Simultaneous in-vivo receptor occupancy assays for serotonin 1A, 2A, and dopamine 2 receptors with the use of non-radiolabelled tracers: Proposed method in screening antipsychotics

Abstract

Introduction: Conventionally, receptor occupancy assays employ radiolabelled tracer. However, recent advances with non-radiolabelled tracers brought a revolution in target engagement assays. Non-radiolabelled tracer based receptor occupancy uses LC-MS/MS based quantification. It offers simultaneous quantification of more than one tracer; thus, provides the feasibility of evaluating multiple targets in a single animal. In the present study, we demonstrated simultaneous measurement of serotonin 1A, serotonin 2A, and dopamine 2 receptor occupancy using non-radiolabelled tracers in rats.

Method: Non-radiolabelled WAY-100635 or MDL-100,907 or raclopride were used as tracers for 5-HT_1A, 5-HT_2A, and D₂ receptors, respectively. In-vivo brain distribution of these tracers was measured after administration as individual or as a mixture of tracers (cocktail tracer). Similarly, in-vitro brain free fractions were evaluated with the single and cocktail tracer in brain homogenates. The mass spectrometer was used for simultaneous quantification of tracers in both in-vivo and in-vitro samples. A ratio method was employed for calculation of receptor occupancy after single and cocktail tracer administration. Pindolol, olanzapine, and ziprasidone were used as tool compounds for demonstrating receptor occupancy at 5-HT_1A, 5-HT_2A, and D₂ receptors.

Result: In optimization studies, regional distribution and concentration ratios (specific to non-specific) of these tracers were unaltered with individual and cocktail tracer. Non-significant variability was observed in brain free fraction of tracers' indicating the minimal binding interactions in this tracer combination. The half-maximal effective dose (ED₅₀) for pindolol (5-HT_1A 1.37 & 2.42mg/kg, i.v.), olanzapine (5-HT_2A 1.37 & 2.12 and D₂ 1.90 & 2.72mg/kg, p.o.), and ziprasidone (5-HT_1A 10.92 & 9.57; 5-HT_2A 0.03 & 0.04 and D₂ 0.11 & 0.08mg/kg, i.v.) were comparable with individual or cocktail tracer.

Discussion: The present study demonstrated the utility of non-radiolabelled tracers in simultaneous measurement of multiple target engagement. Use of this method will minimize the time, in addition to the cost in translational research.

Keywords: 5HT1A; 5HT2A; Acetic acid (PubChem CID: 176); Cocktail tracer; D2; Dimethyl sulfoxide (PubChem CID: 679); Hydroxypropyl beta-cyclodextrin (PubChem CID: 44134771); LC-MS/MS; MDL-100,907 (PubChem CID: 60858); Non-radiolabelled tracer; Occupancy; Olanzapine (PubChem CID: 4585); Pharmasolve-d3 (PubChem CID: 71750536); Pindolol (PubChem CID: 4828); Raclopride (PubChem CID: 3033769); Saline (PubChem CID: 5234); WAY-100635 (PubChem CID: 5684); Ziprasidone (PubChem CID: 60854).